Recce Pharmaceuticals Ltd

ASX:RCE Stok Raporu

Piyasa değeri: AU$103.2m

Recce Pharmaceuticals Yönetim

Yönetim kriter kontrolleri 2/4

Recce Pharmaceuticals CEO'su James Graham, Aug2020 tarihinde atandı, in görev süresi 4.25 yıldır. in toplam yıllık tazminatı A$ 834.51K olup, şirket hissesi ve opsiyonları dahil olmak üzere 62.8% maaş ve 37.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 2.92% ine doğrudan sahiptir ve bu hisseler A$ 3.01M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.2 yıl ve 6 yıldır.

Anahtar bilgiler

James Graham

İcra Kurulu Başkanı

AU$834.5k

Toplam tazminat

CEO maaş yüzdesi62.8%
CEO görev süresi4.3yrs
CEO sahipliği2.9%
Yönetim ortalama görev süresi4.2yrs
Yönetim Kurulu ortalama görev süresi6yrs

Son yönetim güncellemeleri

We Think Shareholders Are Less Likely To Approve A Pay Rise For Recce Pharmaceuticals Ltd's (ASX:RCE) CEO For Now

Nov 01
We Think Shareholders Are Less Likely To Approve A Pay Rise For Recce Pharmaceuticals Ltd's (ASX:RCE) CEO For Now

Recent updates

We Think Shareholders Are Less Likely To Approve A Pay Rise For Recce Pharmaceuticals Ltd's (ASX:RCE) CEO For Now

Nov 01
We Think Shareholders Are Less Likely To Approve A Pay Rise For Recce Pharmaceuticals Ltd's (ASX:RCE) CEO For Now

Here's Why We're Watching Recce Pharmaceuticals' (ASX:RCE) Cash Burn Situation

Feb 13
Here's Why We're Watching Recce Pharmaceuticals' (ASX:RCE) Cash Burn Situation

We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely

Jul 28
We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely

Recce Pharmaceuticals (ASX:RCE) Is In A Good Position To Deliver On Growth Plans

Dec 07
Recce Pharmaceuticals (ASX:RCE) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely

Aug 03
We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely

Recce Pharmaceuticals (ASX:RCE) Is In A Good Position To Deliver On Growth Plans

Mar 08
Recce Pharmaceuticals (ASX:RCE) Is In A Good Position To Deliver On Growth Plans

Need To Know: Recce Pharmaceuticals Ltd (ASX:RCE) Insiders Have Been Selling Shares

Feb 01
Need To Know: Recce Pharmaceuticals Ltd (ASX:RCE) Insiders Have Been Selling Shares

Could The Recce Pharmaceuticals Ltd (ASX:RCE) Ownership Structure Tell Us Something Useful?

Dec 09
Could The Recce Pharmaceuticals Ltd (ASX:RCE) Ownership Structure Tell Us Something Useful?

CEO Tazminat Analizi

James Graham'un ücretlendirmesi Recce Pharmaceuticals'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024AU$835kAU$524k

-AU$18m

Mar 31 2024n/an/a

-AU$14m

Dec 31 2023n/an/a

-AU$11m

Sep 30 2023n/an/a

-AU$12m

Jun 30 2023AU$775kAU$551k

-AU$13m

Mar 31 2023n/an/a

-AU$14m

Dec 31 2022n/an/a

-AU$15m

Sep 30 2022n/an/a

-AU$13m

Jun 30 2022AU$548kAU$328k

-AU$11m

Mar 31 2022n/an/a

-AU$10m

Dec 31 2021n/an/a

-AU$8m

Sep 30 2021n/an/a

-AU$11m

Jun 30 2021AU$2mAU$294k

-AU$14m

Mar 31 2021n/an/a

-AU$13m

Dec 31 2020n/an/a

-AU$13m

Sep 30 2020n/an/a

-AU$9m

Jun 30 2020AU$216kAU$187k

-AU$4m

Mar 31 2020n/an/a

-AU$4m

Dec 31 2019n/an/a

-AU$3m

Sep 30 2019n/an/a

-AU$3m

Jun 30 2019AU$177kAU$155k

-AU$3m

Mar 31 2019n/an/a

-AU$2m

Dec 31 2018n/an/a

-AU$2m

Sep 30 2018n/an/a

-AU$2m

Jun 30 2018AU$160kAU$142k

-AU$2m

Tazminat ve Piyasa: James 'nin toplam tazminatı ($USD 547.04K ), Australian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 299.27K ).

Tazminat ve Kazançlar: James şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

James Graham

4.3yrs

Görev süresi

AU$834,509

Tazminat

Mr. James Hamilton-Bray Graham, B.Com. (Entrepreneurship), GAICD, serves as Chief Executive Officer at Recce Pharmaceuticals Ltd since August 28, 2020 and also serves as Managing Director since 2020. He ha...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
John K. Prendergast
Executive Chairman of the Board6.6yrsAU$380.55k0.13%
A$ 136.5k
James Graham
CEO, MD & Executive Director4.3yrsAU$834.51k2.92%
A$ 3.0m
Michele Dilizia
Chief Scientific Director & Executive Director4.2yrsAU$530.84k1.33%
A$ 1.4m
Justin Ward
Principal Quality Chemist & Executive Directorno dataAU$318.53k0.13%
A$ 134.1k
Arthur Kollaras
Principal Engineer & Head of Manufacturingno dataAU$564.01k0.040%
A$ 41.0k
Alan Dunton
Chief Medical Advisor & Independent Non Executive Directorno dataAU$75.00k0.055%
A$ 56.4k
Justin Reynolds
Chief Financial Officer7yrsVeri yokVeri yok
Daniel Astudillo
Head of Marketing4.8yrsVeri yokVeri yok
Maggie Niewidok
Company Secretary2.2yrsVeri yokVeri yok

4.2yrs

Ortalama Görev Süresi

Deneyimli Yönetim: RCE 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.2 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
John K. Prendergast
Executive Chairman of the Board6.6yrsAU$380.55k0.13%
A$ 136.5k
James Graham
CEO, MD & Executive Director9.4yrsAU$834.51k2.92%
A$ 3.0m
Michele Dilizia
Chief Scientific Director & Executive Director9.4yrsAU$530.84k1.33%
A$ 1.4m
Justin Ward
Principal Quality Chemist & Executive Director5.3yrsAU$318.53k0.13%
A$ 134.1k
Alan Dunton
Chief Medical Advisor & Independent Non Executive Director4.3yrsAU$75.00k0.055%
A$ 56.4k
Alistair McKeough
Non-Executive Director2.2yrsAU$81.25k0.011%
A$ 11.6k

6.0yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: RCE 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6 yıldır).